Physician profile
Lauren Wright
NPI 1275778136
$5,459.15
in general payments reported to CMS, 2019-2025
22 companies · $1,478 in 2025
The $1,478 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $575 · 2022: $1,066 · 2023: $1,289 · 2024: $1,051 · 2025: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,817.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,035.57 | 2021-2025 | |
| Genzyme Corporation | $783.16 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $339.64 | 2022-2025 | Winlevi |
| Novartis Pharmaceuticals Corporation | $297.75 | 2021-2025 | |
| Incyte Corporation | $269.32 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $250.76 | 2021-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $242.88 | 2023-2025 | Zoryve |
| Organon LLC | $208.27 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $206.03 | 2022-2025 | Aklief |
| Verrica Pharmaceuticals INC. | $113.75 | 2023-2025 | Ycanth |
| Amgen INC. | $106.31 | 2024-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $105.36 | 2022-2025 | Tremfya, Stelara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.00 | 2023-2025 | Spevigo, Cyltezo |
| Pfizer INC. | $80.30 | 2024-2025 | |
| Dermavant Sciences, INC. | $76.05 | 2024 | Vtama |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $57.33 | 2025 | Adbry |
| Lilly USA, LLC | $57.21 | 2025 | Ebglyss |
| Biofrontera INC. | $56.64 | 2021-2022 | |
| Botanix Sb INC | $35.71 | 2025 | Sofdra |
| E.R. Squibb & Sons, L.L.C. | $30.59 | 2024-2025 | Sotyktu |
| Ucb, INC. | $18.20 | 2021 | |
| Mayne Pharma Commercial LLC | $6.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.